PlainRecalls
FDA Drug Moderate Class II Terminated

Norepinephrine 4 mg per 250 mL (16 mcg per mL) in 0.9% Sodium Chloride, 250 mL Single Dose bag, packaged in 250 mL x 12 units per case, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-552-01.

Reported: July 26, 2023 Initiated: July 7, 2023 #D-0931-2023

Product Description

Norepinephrine 4 mg per 250 mL (16 mcg per mL) in 0.9% Sodium Chloride, 250 mL Single Dose bag, packaged in 250 mL x 12 units per case, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-552-01.

Reason for Recall

Lack of Assurance of Sterility

Details

Recalling Firm
SterRx, LLC
Units Affected
132,299 bags
Distribution
Nationwide in the USA
Location
Plattsburgh, NY

Frequently Asked Questions

What product was recalled?
Norepinephrine 4 mg per 250 mL (16 mcg per mL) in 0.9% Sodium Chloride, 250 mL Single Dose bag, packaged in 250 mL x 12 units per case, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-552-01.. Recalled by SterRx, LLC. Units affected: 132,299 bags.
Why was this product recalled?
Lack of Assurance of Sterility
Which agency issued this recall?
This recall was issued by the FDA Drug on July 26, 2023. Severity: Moderate. Recall number: D-0931-2023.